These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15879167)

  • 1. Influence of gender, menstrual phase, and oral contraceptive use on immunological changes in response to prolonged cycling.
    Timmons BW; Hamadeh MJ; Devries MC; Tarnopolsky MA
    J Appl Physiol (1985); 2005 Sep; 99(3):979-85. PubMed ID: 15879167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral contraceptive use on female sexual salivary hormones and indirect markers of muscle damage following eccentric cycling in women.
    Mackay K; González C; Zbinden-Foncea H; Peñailillo L
    Eur J Appl Physiol; 2019 Dec; 119(11-12):2733-2744. PubMed ID: 31686212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaerobic power performance and the menstrual cycle: eumenorrheic and oral contraceptive users.
    Bushman B; Masterson G; Nelsen J
    J Sports Med Phys Fitness; 2006 Mar; 46(1):132-7. PubMed ID: 16596112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adolescents' cortisol responses to awakening and social stress; effects of gender, menstrual phase and oral contraceptives. The TRAILS study.
    Bouma EM; Riese H; Ormel J; Verhulst FC; Oldehinkel AJ
    Psychoneuroendocrinology; 2009 Jul; 34(6):884-93. PubMed ID: 19195792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No effect of menstrual cycle phase and oral contraceptive use on endurance performance in rowers.
    Vaiksaar S; Jürimäe J; Mäestu J; Purge P; Kalytka S; Shakhlina L; Jürimäe T
    J Strength Cond Res; 2011 Jun; 25(6):1571-8. PubMed ID: 21399539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of sex, menstrual cycle, and oral contraceptives on cerebrovascular resistance and cardiorespiratory function during Valsalva or standing.
    Abidi S; Nili M; Serna S; Kim S; Hazlett C; Edgell H
    J Appl Physiol (1985); 2017 Aug; 123(2):375-386. PubMed ID: 28522756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menstrual cycle and oral contraceptive use do not modify postexercise heat loss responses.
    Kenny GP; Leclair E; Sigal RJ; Journeay WS; Kilby D; Nettlefold L; Reardon FD; Jay O
    J Appl Physiol (1985); 2008 Oct; 105(4):1156-65. PubMed ID: 18687980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of aerobic fitness status, menstrual cycle phase, and oral contraceptive use on exercise substrate oxidation and metabolic flexibility in females.
    Olenick AA; Pearson RC; Jenkins NT
    Appl Physiol Nutr Metab; 2024 Jan; 49(1):93-104. PubMed ID: 37657080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of menstrual cycle phase and oral contraceptive phase on exercise performance in endurance-trained females.
    Oxfeldt M; Frederiksen LK; Gunnarson T; Hansen M
    J Sports Med Phys Fitness; 2024 Mar; 64(3):236-247. PubMed ID: 38213268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral contraceptives on peak exercise capacity.
    Casazza GA; Suh SH; Miller BF; Navazio FM; Brooks GA
    J Appl Physiol (1985); 2002 Nov; 93(5):1698-702. PubMed ID: 12381756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate and hormonal responses to exercise in women using oral contraceptives.
    Bonen A; Haynes FW; Graham TE
    J Appl Physiol (1985); 1991 May; 70(5):1917-27. PubMed ID: 1864771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sex and menstrual cycle in women on starting speed, anaerobic endurance and muscle power.
    Wiecek M; Szymura J; Maciejczyk M; Cempla J; Szygula Z
    Physiol Int; 2016 Mar; 103(1):127-32. PubMed ID: 27030635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary SIgA responses to acute moderate-vigorous exercise in monophasic oral contraceptive users.
    Hayashida H; Dolan NJ; Hounsome C; Alajmi N; Bishop NC
    Appl Physiol Nutr Metab; 2015 Sep; 40(9):863-7. PubMed ID: 26300012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological changes in response to exercise: influence of age, puberty, and gender.
    Timmons BW; Tarnopolsky MA; Snider DP; Bar-Or O
    Med Sci Sports Exerc; 2006 Feb; 38(2):293-304. PubMed ID: 16531898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menstrual cycle phase and oral contraceptive effects on triglyceride mobilization during exercise.
    Casazza GA; Jacobs KA; Suh SH; Miller BF; Horning MA; Brooks GA
    J Appl Physiol (1985); 2004 Jul; 97(1):302-9. PubMed ID: 14990561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptive phase has no effect on endurance test.
    Rechichi C; Dawson B; Goodman C
    Int J Sports Med; 2008 Apr; 29(4):277-81. PubMed ID: 17990209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics.
    Slayter KL; Ludwig EA; Lew KH; Middleton E; Ferry JJ; Jusko WJ
    Clin Pharmacol Ther; 1996 Mar; 59(3):312-21. PubMed ID: 8653994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of oral contraceptive use on growth hormone in vivo bioactivity following resistance exercise: responses of molecular mass variants.
    Kraemer WJ; Nindl BC; Volek JS; Marx JO; Gotshalk LA; Bush JA; Welsch JR; Vingren JL; Spiering BA; Fragala MS; Hatfield DL; Ho JY; Maresh CM; Mastro AM; Hymer WC
    Growth Horm IGF Res; 2008 Jun; 18(3):238-44. PubMed ID: 18037316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise intensity-dependent changes in the inflammatory response in sedentary women: role of neuroendocrine parameters in the neutrophil phagocytic process and the pro-/anti-inflammatory cytokine balance.
    Giraldo E; Garcia JJ; Hinchado MD; Ortega E
    Neuroimmunomodulation; 2009; 16(4):237-44. PubMed ID: 19365147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of sex, menstrual cycle, and oral contraceptives on the number and activity of natural killer cells.
    Yovel G; Shakhar K; Ben-Eliyahu S
    Gynecol Oncol; 2001 May; 81(2):254-62. PubMed ID: 11330959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.